Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer-Reference-Cited by-同舟云学术

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer

Published:2021-04-01 Issue:4 Volume:7 Page:544
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Feng Felix Y.¹²³,Huang Huei-Chung⁴,Spratt Daniel E.⁵,Zhao Shuang (George)⁵,Sandler Howard M.⁶,Simko Jeffry P.⁷,Davicioni Elai⁴,Nguyen Paul L.⁸,Pollack Alan⁹,Efstathiou Jason A.¹⁰,Dicker Adam P.¹¹,Todorovic Tamara⁴,Margrave Jennifer⁴,Liu Yang (Seagle)⁴,Dabbas Bashar⁴,Thompson Darby J. S.¹²,Das Rajdeep¹²³,Dignam James J.¹³¹⁴,Sweeney Christopher¹⁵,Attard Gerhardt¹⁶,Bahary Jean-Paul¹⁷,Lukka Himanshu R.¹⁸,Hall William A.¹⁹,Pisansky Thomas M.²⁰,Shah Amit B.²¹,Pugh Stephanie L.¹³,Shipley William U.¹⁰,Tran Phuoc T.²²²³²⁴

Affiliation:

1. Department of Radiation Oncology, UCSF Medical Center, San Francisco, California

2. Department of Medicine, UCSF Medical Center, San Francisco, California

3. Department of Urology, UCSF Medical Center, San Francisco, California

4. Decipher Biosciences, San Diego, California

5. Department of Radiation Oncology, University of Michigan, Ann Arbor

6. Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California

7. NRG Biorepository, Department of Pathology, UCSF Medical Center, San Francisco, California

8. Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts

9. Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, Florida

10. Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts

11. Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

12. Emmes Canada, Vancouver, British Columbia, Canada

13. NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania

14. Department of Public Health, University of Chicago, Chicago, Illinois

15. Department of Medicine, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts

16. Department of Oncology, University College London, London, United Kingdom

17. Department of Radiation Oncology, Centre Hospitalier de l’Université de Montréal-Notre Dame, Montreal, Quebec, Canada

18. Department of Radiation Oncology, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

19. Department of Radiation Oncology, Froedtert and the Medical College of Wisconsin, Madison, Wisconsin

20. Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota

21. Department of Radiation Oncology, WellSpan Health-York Cancer Center accruals under Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

22. Department of Radiation Oncology, Johns Hopkins University, Baltimore, Maryland

23. Department of Oncology, Johns Hopkins University, Baltimore, Maryland

24. Department of Urology, Johns Hopkins University, Baltimore, Maryland

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2776225/jamaoncology_feng_2021_oi_200112_1617385026.41601.pdf

Reference17 articles.

1. Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer.;Spratt;J Clin Oncol,2018

2. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.;Erho;PLoS One,2013